Ensign Peak Advisors »

Nurix Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0M 180k 22.47
2024-06-30 $744k 36k 20.87
2024-03-31 $1.2M 80k 14.70
2023-09-30 $628k 80k 7.86
2023-06-30 $798k 80k 9.99
2023-03-31 $710k 80k 8.88
2022-12-31 $877k 80k 10.98
2022-09-30 $1.1M 87k 13.03
2022-06-30 $1.1M 85k 12.67
2022-03-31 $1.2M 85k 14.01
2021-12-31 $142k 4.9k 29.04
2021-09-30 $24k 799 30.04
2021-06-30 $21k 799 26.28
2021-03-31 $25k 799 31.29
2020-12-31 $26k 799 32.54
2020-09-30 $28k 799 35.04